Pingleton SK, Harmon GS. Nutritional management in acute respiratory failure.
JAMA 1987;257:3094–9.
Fiaccadori E, Del Canale S, Coffrini E, et al. Hypercapnic-hypoxemic chronic
obstructive pulmonary disease (COPD): influence of severity of COPD on nutritional status.
Am J Clin Nutr 1988;48:680–5.
Efthimiou J, Mounsey PJ, Bensen DN, et al. Effect of carbohydrate rich versus
fat rich loads on gas exchange and walking performance in patients with chronic obstructive
lung disease. Thorax 1992;47:451–6.
Miedema I, Feskens EJM, Heederik D, et al. Dietary determinants of long-term
incidence of chronic nonspecific lung diseases. Am JEpidemiol
1993;138:37–45.
Businco L, Businco E. Allergic pathogenesis in chronic bronchitis.
Allergol Immunopathol (Madr) 1975;3:1–8.
Krawczyk Z. Role of allergy of the immediate type in the pathogenesis of
chronic bronchitis in adults. Pneumonol Pol 1976;44:829–36 [in Polish].
No author listed. Preliminary study on the relation between allergy and
chronic bronchitis. Chin Med J 1976;2:63–8.
Rowe AH, Rowe A Jr, Sinclair C. Food allergy: its role in the symptoms of
obstructive emphysema and chronic bronchitis. J Asthma Res 1967;5:11–20.
Van Schayck CP, Dekhuijzen PN, Gorgels WJ, et al. Are anti-oxidant and
anti-inflammatory treatments effective in different subgroups of COPD? A hypothesis.
Respir Med 1998;92:1259–64.
Boman G, Bäcker U, Larsson S, et al. Oral acetylcysteine reduces
exacerbation rate in chronic bronchitis: a report of a trial organized by the Swedish Society
for Pulmonary Diseases. Eur J Respir Dis 1983;64:405–15.
Multicenter Study Group. Long-term oral acetylcysteine in chronic bronchitis.
A double-blind controlled study. Eur J Respir Dis 1980;61:111:93–108.
Dal Negro R, Pomari G, Zoccatelli O, Turco P. L-carnitine and rehabilitative
respiratory physiokinesitherapy: metabolic and ventilatory response in chronic respiratory
insufficiency. Int J Clin Pharmacol Ther Toxicol 1986;24:453–6.
Dal Negro R, Turco P, Pomari C, De Conti F. Effects of L-carnitine on physical
performance in chronic respiratory insufficiency. Int J Clin Pharmacol Ther Toxicol
1988;26:269–72.
Sridhar MK. Nutrition and lung health. BMJ 1995;310:75–6.
Shahar E, Folsom AR, Melnick SL, et al. Dietary n-3 polyunsaturated fatty
acids and smoking-related chronic obstructive pulmonary disease. Atherosclerosis Risk in
Communities Study Investigators. N Engl J Med 1994;331:228–33.
Rolla G, Bucca C, Bugiani M, et al. Hypomagnesemia in chronic obstructive lung
disease: effect of therapy. Magnesium Trace Elem 1990;9:132–6.
Fiaccadori E, Del Canale S, Coffrini E, et al. Muscle and serum magnesium in
pulmonary intensive care unit patients. Crit Care Med 1988;16:751–60.
Skorodin MS, Tenholder MF, Yetter B, et al. Magnesium sulfate in exacerbations
of chronic obstructive pulmonary disease. Arch Intern Med
1995;155:496–500.
Okayama H, Aikawa T, Okayama M, et al. Bronchodilating effect of intravenous
magnesium sulfate in bronchial asthma. JAMA 1987;257:1076–8.
Fujimoto S, Kurihara N, Hirata K, Takeda T. Effects of coenzyme Q10
administration on pulmonary function and exercise performance in patients with chronic lung
diseases. Clin Investig 1993;71(8 Suppl):S162–6.
Rautalahti M, Virtamo J, Haukka J, et al. The effect of alpha-tocopherol and
beta-carotene supplementation on COPD symptoms. Am J Respir Crit Care Med
1997;156:1447–52.
Meyer-Wegner J. Ivy versus ambroxol in chronic bronchitis. Zeits
Allegemeinmed 1993;69:61–6 [in German].
Hoffman D. The Herbal Handbook: A User’s Guide to Medical
Herbalism. Rochester, VT: Healing Arts Press, 1988, 67.